Sequence evolution of putative cytotoxic T cell epitopes in NS3 region of hepatitis C virus

World Journal of Gastroenterology

Volumn 10, Issue 6, 2004, Pages 847-851

  Guo, Hua Zhang ^a   Yin, Ying ^a   Wang, Wen Liang ^a   Zhang, Chuan Shan ^a   Wang, Tao ^a   Wang, Zhe ^a   Zhang, Jing ^a   Cheng, Hong ^a   Wang, Hai Tong ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; EPITOPE; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CASE REPORT; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE SEQUENCE; HEPATITIS C; HEPATITIS C VIRUS; HLA TYPING; HUMAN; LYMPHOCYTOTOXICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEQUENCE ANALYSIS;

EID: 1842535047     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i6.847     Document Type: Article

References (40)

1. National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology 1997; 26(3 Suppl): 2S-10S
2. Maier I, Wu GY. Hepatitis C and HIV co-infection: a review. World J Gastroenterol 2002; 8: 577-579
3. Meier V, Mihm S, Braun Wietzke P, Ramadori G. HCV-RNA positivity in peripheral blood mononuclear cells of patients with chronic HCV infection: does it really mean viral replication? World J Gastroenterol 2001; 7: 228-234
4. Chen MY, Huang ZQ, Chen LZ, Gao YB, Peng RY, Wang DW. Detection of hepatitis C virus NS5 protein and genome in Chinese carcinoma of the extrahepatic bile duct and its significance. World J Gastroenterol 2000; 6: 800-804
5. He QQ, Cheng RX, Sun Y, Feng DY, Chen ZC, Zheng H. Hepatocyte transformation and tumor development induced by hepatitis C virus NS3 c-terminal deleted protein. World J Gastroenterol 2003; 9: 474-478
6. Li K, Wang L, Cheng J, Lu YY, Zhang LX, Mu JS, Hong Y, Liu Y, Duan HJ, Wang G, Li L, Chen JM. Interaction between hepatitis C virus core protein and translin protein-a possible molecular mechanism for hepatocellular carcinoma and lymphoma caused by hepatitis C virus. World J Gastroenterol 2003; 9: 300-303
7. Worman HJ, Lin F. Molecular biology of liver disorders:the hepatitis C virus and molecular targets for drug development. World J Gastroenterol 2000; 6: 465-469
8. Nelson DR, Marousis CG, Davis GL, Rice CM, Wong J, Houghton M, Lau JY. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 1997; 158: 1473-1481
9. Assy N, Minuk G. A comparison between previous and present histologic assessments of chronic hepatitis C viral infections in humans. World J Gastroenterol 1999; 5: 107-110
10. Caselmann WH, Serwe M, Lehmann T, Ludwig J, Sproat BS, Engels JW. Design, delivery and efficacy testing of therapeutic nucleic acidsused to inhibit hepatitis C virus gene expression in vitro and in vivo. World J Gastroenterol 2000; 6: 626-629
11. Chen LK, Hwang SJ, Tsai ST, Luo JC, Lee SD, Chang FY. Glucose intolerance in Chinese patients with chronic hepatitis C. World J Gastroenterol 2003; 9: 505-508
12. Fan XG, Tang FQ, Ou ZM, Zhang JX, Liu GC, Hu GL. Lymphoproliferative response to hepatitis C virus (HCV) antigens in patients with chronic HCV infection. Shijie Huaren Xiaohua Zazhi 1999; 7: 1038-1040
13. Song ZQ, Hao F, Zhang J, Gu CH. Detection of antibodies against hypervariable region 1 in sera from patients with hepatitis C. Shijie Huaren Xiaohua Zazhi 1999; 7: 666-668
14. Wit HB, Li ZW, Li Y. Clinical significance of detection of positive and negative strands of HCV RNA in peripheral blood mononuclear cells. Shijie Huaren Xiaohua Zazhi 1999; 7: 220-221
15. Zhou YX, Feng ZH, Jia ZS, Lian JQ, Li JG, Li WB. A study of gene immunization with recombinant expression plasmid of hepatitis C virus core antigen. Shijie Huaren Xiaohua Zazhi 1998; 6: 966-968
16. Major ME, Feinstone SM. The molecular virology of hepatitis C. Hepatology 1997; 25: 1527-1538
17. Chen S, Wang YM. Genetic evolution of structural region of hepatitis C virus in primary infection. World J Gastroenterol 2002; 8: 686-693
18. Flichman D, Kott V, Sookoian S, Campos R. Acute hepatitis C in a chronically HIV-infected patient: Evolution of different viral genomic regions. World J Gastroenterol 2003; 9: 1496-1500
19. Chen YD, Liu MY, Yu WL, Li JQ, Dai Q, Zhou ZQ, Tisminetzky SG. Mix-infections with different genotypes of HCV and with HCV plus other hepatitis viruses in patients with hepatitis C in China. World J Gastroenterol 2003; 9: 984-992
20. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford K, Marion CD, Crawford KA. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci U S A 1992; 89: 3468-3472
21. Rehermann B, Chang KM, McHutchison JG, Kokka R, Houghton M, Chisari FV. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 1996; 98: 1432-1440
22. Li CP, Wang KX, Wang J, Pan BR. mIL-2R, T cell subsets & hepatitis C. World J Gastroenterol 2002; 8: 298-300
23. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159
24. Rehermann B, Chang KM, McHutchinson J, Kokka R, Houghton M, Rice CM, Chisari FV. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 1996; 70: 7092-7102
25. Guo H, Wang W, Wang T. An application of T cell epitope prediction computer program in the study of HCV adaptive immune responses. Disi Junyi Daxue Xuebao 1999; 20: 845-848
26. Huang F, Zhao GZ, Li Y. HCV genotypes in hepatitis C patients and their clinical significances. World J Gastroenterol 1999; 5: 547-549
27. Elena SF, Miralles R, Cuevas JM, Turner PE, Moya A. The two faces of mutation: extinction and adaptation in RNA viruses. IUBMB Life 2000; 49: 5-9
28. Wodarz D. Hepatitis C virus dynamics and pathology: the role of CTL and antibody responses. J Gen Virol 2003; 84(Pt 7): 1743-1750
29. Encke J, zu Putlitz J, Geissler M, Wands JR. Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model. J Immunol 1998; 161: 4917-4923
30. Wertheimer AM, Miner C, Lewinsohn DM, Sasaki AW, Kaufman E, Rosen HR. Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. Hepatology 2003; 37: 577-589
31. Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, Gomez J. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992; 66: 3225-3229
32. Higashi Y, Kakumu S, Yoshioka K, Wakita T, Mizokami M, Ohba K, Ito Y, Ishikawa T, Takayanagi M, Nagai Y. Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 1993; 197: 659-668
33. Androlewicz MJ. Peptide generation in the major histocompatibility complex class I antigen processing and presentation pathway. Curr Opin Hematol 2001; 8: 12-16
34. Khan AR, Baker BM, Ghosh P, Biddison WE, Wiley DC. The structure and stability of an HLA-A0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site. J Immunol 2000; 164: 6398-6405
35. Sliz P, Michielin O, Cerottini JC, Luescher I, Romero P, Karplus M, Wiley DC. Crystal structures of two closely related but antigenically distinct HLA-A2/melanocyte-melanoma tumor-antigen peptide complexes. J Immunol 2001; 167: 3276-3284
36. Davenport MP, Smith KJ, Barouch D, Reid SW, Bodnar WM, Willis AC, Hunt DF, Hill AV. HLA class I binding motifs derived from random peptide libraries differ at the COOH terminus from those of eluted peptides. J Exp Med 1997; 185: 367-371
37. Zhou HC, Xu DZ, Wang XP, Zhang JX, Huang Y, Yan YP, Zhu Y, Jin BQ. Identification of the epitopes on HCV core protein recognized by HLA-A2 restricted cytotoxic T lymphocytes. World J Gastroenterol 2001; 7: 583-586
38. Reche PA, Glutting JP, Reinherz EL. Prediction of MHC class I binding peptides using profile motifs. Hum Immunol 2002; 63: 701-709
39. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999; 50: 213-219
40. Guo HC, Jardetzky TS, Garrett TP, Lane WS, Strominger JL, Wiley DC. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature 1992; 360: 364-366